Andrew Kroetsch

Title: Andrew Kroetsch: Innovator in Lentiviral Vector Formulations

Introduction

Andrew Kroetsch is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of lentiviral vector formulations. His work focuses on improving the stability of these formulations for systemic administration, which has important implications for treating various disorders.

Latest Patents

Andrew Kroetsch holds 1 patent related to lentiviral vector formulations. His patent details the development of lentiviral vector (LV) formulations and pharmaceutical compositions that exhibit improved stability. These formulations are designed for systemic administration and are particularly useful in treating blood disorders.

Career Highlights

Throughout his career, Andrew has worked with prominent organizations in the biotechnology sector. He has been associated with Fondazione Telethon, where he contributed to research initiatives aimed at advancing gene therapy. Additionally, he has worked at Bioverativ Therapeutics Inc., a company focused on developing innovative treatments for hemophilia and other blood disorders.

Collaborations

Andrew Kroetsch has collaborated with Isidro Zarraga, enhancing the research and development efforts in the field of lentiviral vectors. Their combined expertise has contributed to advancements in therapeutic applications.

Conclusion

Andrew Kroetsch's work in lentiviral vector formulations represents a significant advancement in biotechnology. His innovative approaches have the potential to improve treatment options for patients with blood disorders.